E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers T > Headlines for Teva Pharmaceutical Finance Netherlands III BV > News item
Published on 3/1/2023 in the Prospect News Bank Loan Daily, Prospect News Convertibles Daily, Prospect News Emerging Markets Daily, Prospect News Green Finance Daily and Prospect News High Yield Daily.

Fitch assigns BB- to Teva notes

Fitch Ratings said it assigned BB-/RR4 ratings to the offering of sustainability-linked, senior unsecured notes by Teva Pharmaceutical Finance Netherlands II BV and Teva Pharmaceutical Finance Netherlands III BV, which are indirect, wholly-owned subsidiaries of Teva Pharmaceutical Industries Ltd., which is rated BB-.

Teva is expected to use the proceeds with cash on hand to repay outstanding debt upon maturity, to tender or to redeem early debt.

The outlook is stable.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.